Aoxing Pharmaceutical Co., Ltd. (OTCMKTS:AOXG) is a China-based pharmaceutical company primarily engaged in the research, development, manufacturing and distribution of a diverse range of pharmaceutical products. Founded in 2000 and headquartered in Shandong Province, the company has built a comprehensive production infrastructure that adheres to national Good Manufacturing Practice (GMP) standards. Its facilities are equipped for the large-scale production of solid oral dosage forms, including tablets and capsules, as well as traditional Chinese medicine (TCM) formulations, catering to both modern and herbal treatment segments.
The company’s product portfolio spans several therapeutic areas, with a focus on cardiovascular health, central nervous system disorders and anti-inflammatory agents. Among its offerings are generic small-molecule drugs, Chinese patent medicines and health supplements. Aoxing Pharmaceutical also develops proprietary TCM formulas that integrate herbal extracts with standardized quality controls, reflecting its dual expertise in Western and traditional medicines. These products are distributed through a nationwide sales network covering more than 20 provinces and municipalities in China.
Over the years, Aoxing Pharmaceutical has expanded its reach beyond its domestic market by forging export partnerships in Southeast Asia, the Middle East and parts of Africa. The company’s international operations are supported by strategic alliances with regional distributors, enabling it to navigate local regulatory requirements and enhance its product availability. Aoxing has also invested in cold-chain logistics for temperature-sensitive formulations, ensuring consistent product integrity during transit.
Led by Chairman Li Jun and CEO Wang Wei, Aoxing’s management team combines industry veterans in pharmaceutical R&D, quality assurance and commercial strategy. The company maintains active collaborations with academic institutions and contract research organizations to bolster its pipeline of new chemical and botanical entities. As it advances its R&D capabilities, Aoxing Pharmaceutical remains committed to expanding its therapeutic offerings and strengthening its position in both domestic and international markets.
AI Generated. May Contain Errors.
